{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:13:58Z","timestamp":1761920038034},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cancergeneticsjournal.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.cancergen.2015.08.002","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T00:35:22Z","timestamp":1440808522000},"page":"525-536","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A multicenter, cross-platform clinical validation study of cancer cytogenomic arrays"],"prefix":"10.1016","volume":"208","author":[{"given":"Marilyn M.","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico A.","family":"Monzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaclyn A.","family":"Biegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaidehi","family":"Jobanputra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J.","family":"Laffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brynn","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Miron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokce","family":"Toruner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Doho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret J.","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shera","family":"Kash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna","family":"Streck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iya","family":"Znoyko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill M.","family":"Hagenkord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daynna J.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2015.08.002_bib0010","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/leu.2013.305","article-title":"Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS","volume":"28","author":"List","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0015","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1158\/1078-0432.CCR-13-0138","article-title":"Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia","volume":"19","author":"Ouillette","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0020","author":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0025","author":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0030","author":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cancergen.2011.06.001","article-title":"Clinical genomics of renal epithelial tumors","volume":"204","author":"Hagenkord","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00776-007-1215-1","article-title":"Advantages and limitations of cytogenetic, molecular cytogenetic, and molecular diagnostic testing in mesenchymal neoplasms","volume":"13","author":"Bridge","year":"2008","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0045","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ajhg.2010.04.006","article-title":"Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies","volume":"86","author":"Miller","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PDM.0b013e3181d527c5","article-title":"Reproducibility and performance of virtual karyotyping with SNP microarrays for the detection of chromosomal imbalances in formalin-fixed paraffin embedded tissues","volume":"19","author":"Alvarez","year":"2010","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cancergen.2012.01.014","article-title":"Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors","volume":"205","author":"Dougherty","year":"2012","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0060","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ajmg.a.32116","article-title":"Characterization of a cryptic 3.3 Mb deletion in a patient with a \u201cbalanced t(15;22) translocation\u201d using high density oligo array CGH and gene expression arrays","volume":"146A","author":"Li","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/PDM.0b013e31815aca30","article-title":"Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for routine clinical use on formalin-fixed paraffin-embedded tissues","volume":"17","author":"Lyons-Weiler","year":"2008","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0070","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1158\/0008-5472.CAN-05-0465","article-title":"A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays","volume":"65","author":"Nannya","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/518809","article-title":"Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of Affymetrix single-nucleotide-polymorphism genotyping microarrays","volume":"81","author":"Yamamoto","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0080","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0085","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2012.06.006","article-title":"An overview of renal cell cancer: pathology and genetics","volume":"23","author":"Moch","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-4608(96)00289-0","article-title":"Cytogenetic classification of renal cell cancer","volume":"95","author":"van den Berg","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.beha.2013.09.004","article-title":"Morphology, cytogenetics and classification of MDS","volume":"26","author":"Giagounidis","year":"2013","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0105","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.seminhematol.2012.07.001","article-title":"Lenalidomide for del(5q) and non-del(5q) myelodysplastic syndromes","volume":"49","author":"Giagounidis","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.beha.2013.10.013","article-title":"Deletion 5q MDS: molecular and therapeutic implications","volume":"26","author":"Komrokji","year":"2013","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0115","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s001090050350","article-title":"Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis","volume":"77","author":"D\u00f6hner","year":"1999","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cancergen.2014.01.004","article-title":"Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants","volume":"207","author":"Laurie","year":"2014","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0125","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/onc.2012.411","article-title":"The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia","volume":"32","author":"Malek","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0130","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1182\/blood-2007-11-122028","article-title":"High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival","volume":"112","author":"Starczynowski","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jpeds.2009.04.001","article-title":"Clinical application of microarray-based molecular cytogenetics: an emerging new era of genomic medicine","volume":"155","author":"Li","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature14493","article-title":"Chromothripsis from DNA damage in micronuclei","volume":"522","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0145","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrc3352","article-title":"Chromothripsis and cancer: causes and consequences of chromosome shattering","volume":"12","author":"Forment","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0150","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3346\/jkms.2014.29.7.926","volume":"29","author":"Koh","year":"2014","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0155","author":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0160","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cancergen.2013.09.001","article-title":"The advantage of using SNP array in clinical testing for hematological malignancies\u2014a comparative study of three genetic testing methods","volume":"206","author":"Xu","year":"2013","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0165","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/1471-2164-9-379","article-title":"Comparison of the Agilent, ROMA\/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors","volume":"9","author":"Baumbusch","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0170","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nbt.1852","article-title":"Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants","volume":"29","author":"Pinto","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0175","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/1471-2164-10-588","article-title":"The pitfalls of platform comparison: DNA copy number array technologies assessed","volume":"10","author":"Curtis","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.cancergen.2015.08.002_bib0180","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/gim.2013.49","article-title":"American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders","volume":"15","author":"Cooley","year":"2013","journal-title":"Genet Med"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776215001817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776215001817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T18:55:17Z","timestamp":1599504917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776215001817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S2210776215001817"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2015.08.002","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multicenter, cross-platform clinical validation study of cancer cytogenomic arrays","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2015.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}